3
Announcements
Trials
Browse
Landscape
Status
Completed
43
Terminated
17
Recruiting
12
Unknown
7
Active not recruiting
7
Withdrawn
3
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Colorectal Neoplasms
11
Pancreatic Neoplasms
6
Nasopharyngeal Carcinoma
5
Cholangiocarcinoma
4
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Cirrhosis, Familial, with Pulmonary Hypertension
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Urinary Bladder Neoplasms
1
Rare Tumour
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Chemotherapy
1
Muscle Neoplasms
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Keratosis, Actinic
1
HER2-positive Gastric Cancer
1
Gastrointestinal Neoplasms
1
Interventions
Exercise
9
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Anastrozole
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Fluorouracil
×
Clear all
NCT06154590
2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
100 enrolled